Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

DocuSign stock slides today as software names wobble — here’s what’s driving DOCU

DocuSign stock slides today as software names wobble — here’s what’s driving DOCU

New York, Jan 2, 2026, 15:43 ET — Regular session DocuSign (DOCU.O) shares fell 4.4% to $65.38 in afternoon trade on Friday, after earlier swinging between $69.00 and $64.25. About 2.2 million shares had changed hands, compared with the stock’s previous close of $68.40. The slide comes as Wall Street’s first session of 2026 turned cautious after last year’s strong run, with the S&P 500 and Nasdaq slipping from early gains. “Stocks trade expensive on 18 of 20 measures, and we see elevated risks to the index level in the near term,” Savita Subramanian, Bank of America’s equity and quant
2 January 2026
·······
MongoDB stock drops about 4% in late trade as software sector slides — what’s next for MDB

MongoDB stock drops about 4% in late trade as software sector slides — what’s next for MDB

New York, January 2, 2026, 15:34 ET — Regular session MongoDB, Inc. shares slid about 4% in afternoon trading on Friday, falling to around $402 and underperforming the broader market as software stocks weakened on the first trading day of 2026. The move matters because MongoDB trades like a classic “risk-on” software stock — the kind that can swing hard when investors reassess valuations and interest-rate expectations. “Stocks trade expensive on 18 of 20 measures,” Bank of America equity and quant strategist Savita Subramanian wrote in a note. Reuters Software was a notable drag: the iShares Expanded Tech-Software Sector ETF
2 January 2026
·······
Kymera Therapeutics stock slides nearly 7% after CEO share-sale filing — what KYMR investors watch next

Kymera Therapeutics stock slides nearly 7% after CEO share-sale filing — what KYMR investors watch next

NEW YORK, Jan 2, 2026, 15:39 ET — Regular session Kymera Therapeutics Inc (KYMR.O) shares fell nearly 7% on Friday afternoon after a regulatory filing disclosed a year-end sale by Chief Executive Nello Mainolfi. Kymera was down 6.9% at $72.42, after earlier touching $72.18. The move matters because Kymera has become a high-sensitivity biotech name, with investor expectations tied closely to clinical progress for its experimental immunology drug KT-621. In that setup, insider selling can test sentiment, even when the transactions are scheduled in advance. Friday’s drop stood out against a steadier tape. The SPDR S&P Biotech ETF (XBI) was
2 January 2026
····
Palantir stock drops 5% today as 2026 kicks off; PLTR slips below key technical levels

Palantir stock drops 5% today as 2026 kicks off; PLTR slips below key technical levels

NEW YORK, Jan 2, 2026, 15:29 ET — Regular session Palantir Technologies Inc. (PLTR) shares fell 5.2% to $168.43 in afternoon trading on Friday, the first session of 2026. The stock ranged from $166.38 to $182.93, with about 49.3 million shares changing hands. The drop comes after a sharp 2025 run that left the stock sensitive to early-year repositioning. TipRanks said Palantir rose more than 136% in 2025 and noted the shares were hovering near chart levels traders track, including a 50-day moving average around $181.20; TipRanks also showed a “Hold” consensus rating and an average price target of $187.87.
2 January 2026
·····
Dyne Therapeutics (DYN) stock slides today as biotech wobbles — FDA clock back in focus

Dyne Therapeutics (DYN) stock slides today as biotech wobbles — FDA clock back in focus

NEW YORK, Jan 2, 2026, 3:19 PM ET — Regular session Dyne Therapeutics shares fell about 6% on Friday, giving back earlier gains in a volatile first session of 2026 for some biotech names. The Nasdaq-listed stock was down 6.1% at $18.36 in afternoon trading, after touching $20.90 at the high and $18.13 at the low. The move matters because it pulls Dyne back toward the $18.44 price of its December share sale, a reference point traders often watch after a dilutive financing. Dyne said that offering raised about $402.5 million in gross proceeds. The broader tape offered little help.
2 January 2026
····
Novanta stock dives nearly 6% today as 2026 starts — why NOVT is lagging peers

Novanta stock dives nearly 6% today as 2026 starts — why NOVT is lagging peers

NEW YORK, Jan 2, 2026, 15:29 ET — Regular session Novanta Inc shares were down 5.9% at $111.99 in afternoon trading on Friday, after opening near $119.89 and sliding to a session low of $110.46. The stock last traded about $7 lower on the day, with about 435,000 shares changing hands. The drop matters because it came on the first trading day of 2026, when portfolio rebalancing can amplify moves in mid-cap industrial technology names. It also stood out against gains in related laser and photonics stocks, leaving Novanta as a laggard even as investors chased strength elsewhere in the
2 January 2026
·····
BILL stock drops about 6% as Wall Street turns choppy to start 2026

BILL stock drops about 6% as Wall Street turns choppy to start 2026

NEW YORK, Jan 2, 2026, 15:16 ET — Regular session BILL Holdings, Inc. (NYSE: BILL) shares were down 6.3% at $51.11 in mid-afternoon trading on Friday, after sliding from an early high and touching a session low of $50.73. The stock last closed at $54.54. The drop came as U.S. stocks wobbled in the first session of 2026, with investors rotating toward chipmakers even as the broader market softened. “Stocks trade expensive on 18 of 20 measures,” Bank of America strategist Savita Subramanian wrote, flagging elevated near-term risks for equities. Reuters For BILL, the timing matters because the company just
2 January 2026
·····
SailPoint stock sinks 6% today: what’s driving SAIL and what to watch next

SailPoint stock sinks 6% today: what’s driving SAIL and what to watch next

NEW YORK, Jan 2, 2026, 15:10 ET — Regular session Shares of SailPoint, Inc. fell about 6.5% on Friday, giving the identity security software maker one of the sharpest declines among mid-cap cybersecurity stocks. The drop matters because investors are opening the new year reassessing risk after 2025’s strong run, with attention shifting back to valuations and the interest-rate outlook that tends to drive high-growth software. Reuters “Stocks trade expensive on 18 of 20 measures,” said Savita Subramanian, Bank of America’s equity and quant strategist, in a note, as investors looked ahead to next week’s labor-market data for clues on
2 January 2026
·····
Neptune Insurance (NP) stock drops 4% in 2026’s first session as risk appetite cools

Neptune Insurance (NP) stock drops 4% in 2026’s first session as risk appetite cools

NEW YORK, Jan 2, 2026, 15:01 ET — Regular session Neptune Insurance Holdings Inc (NYSE: NP) shares fell about 4% to $27.99 in afternoon trading on Friday, underperforming the broader market in the first U.S. session of 2026. The move matters because Neptune is a recently listed name that has drawn momentum interest, and early-year rebalancing can amplify swings in smaller, newer stocks. It also lands as investors refocus on the macro outlook for rates and growth, a key driver for insurance-related valuations because insurers invest premiums largely in bonds and rate expectations can change sector sentiment quickly. U.S. stocks
2 January 2026
·····
Spyre Therapeutics stock sinks 7% today: what’s pressuring SYRE and what investors watch next

Spyre Therapeutics stock sinks 7% today: what’s pressuring SYRE and what investors watch next

NEW YORK, Jan 2, 2026, 14:37 ET — Regular session Shares of Spyre Therapeutics, Inc. slid about 7% on Friday, falling to $30.48 in afternoon trading after touching a session low of $30.11. The stock opened at $32.76 and was last down $2.28 on the day. The move left Spyre underperforming the broader biotech tape, with the SPDR S&P Biotech ETF down about 0.7% and the iShares Nasdaq Biotechnology ETF off about 0.2%. “Money managers are waiting to see … the vibe for the coming year,” said Thomas Martin, senior portfolio manager at Globalt, describing the first-session tone in U.S.
2 January 2026
·····
Why Pegasystems stock is sliding today: PEGA drops 6% as 2026 trading opens

Why Pegasystems stock is sliding today: PEGA drops 6% as 2026 trading opens

NEW YORK, Jan 2, 2026, 15:03 ET — Regular session Shares of Pegasystems Inc were down 6.2% at $56.01 in afternoon trading on Friday, after ending the prior session at $59.69, according to Google Finance data. Google The drop stands out on the first trading day of 2026, a moment when investors often reset positioning and recheck what they are paying for growth. That reassessment has hit high-multiple stocks hardest as markets debate whether last year’s momentum can carry into the new year. “Stocks trade expensive on 18 of 20 measures,” Savita Subramanian, Bank of America’s equity and quant strategist,
2 January 2026
·····
Polestar stock swings, down 6% as BBVA reveals 8.4% stake in SEC filing

Polestar stock swings, down 6% as BBVA reveals 8.4% stake in SEC filing

NEW YORK, January 2, 2026, 14:50 ET — Regular session Polestar Automotive Holding UK PLC shares fell 6.4% to $20.01 in afternoon trading on Friday, after swinging between $23.29 and $19.67 earlier in the session. The move put fresh focus on the electric-vehicle maker’s capital structure after it announced late last month it would raise $300 million in equity and pursue a separate debt-to-equity conversion with a Geely affiliate. SEC Polestar CEO Michael Lohscheller said the deals “significantly enhance our liquidity position and help strengthen our balance sheet,” in the Dec. 19 announcement. SEC A Schedule 13G filed with the
2 January 2026
·····
1 … 437 438 439 440 441 … 881

Stock Market Today

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

7 February 2026
PLS Group shares closed at A$4.12 Friday, down 1.2% after a 3.7% drop Thursday. Morgan Stanley and Mitsubishi UFJ Financial Group disclosed increased voting power in the lithium miner, both citing changes dated Feb. 2. The moves came as lithium prices fell and Australian equities posted their sharpest drop in months. PLS reports interim results Feb. 19.
Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

7 February 2026
Commonwealth Bank of Australia shares closed at A$158.91, down 0.23% Friday, as the S&P/ASX 200 fell 2.03% and nearly A$70 billion was wiped from the market. The bank reports half-year results and an interim dividend on Feb. 11, with shares going ex-dividend Feb. 18. CBA flagged a A$68 million provision linked to ASIC’s Better Banking review. The RBA raised rates to 3.85% on Feb. 3, with CBA passing on the increase from Feb. 13.
Go toTop